Login to Your Account

EMA seeks to improve ATMP pathway; first Prime projects named

By Nuala Moran
Staff Writer

Wednesday, June 8, 2016

LONDON – Under pressure from the European Commission, industry and patients' groups, the EMA has solicited and published proposals for improving the way it regulates cell, gene and tissue therapies, with the aim of speeding approvals and expanding patient access.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription